private placement
Sarepta Extends $700M Debt to 2030, Adds Private Placement Amid Elevidys Uncertainty
Sarepta Therapeutics; debt maturity extension; convertible notes; private placement; Elevidys; financial strategy; biopharma
Cullinan Secures $280M in Private Placement to Enter Autoimmune Market
Cullinan, Private Placement, $280M, Autoimmune Market, Biotechnology